NCT00122694View on ClinicalTrials.gov

Modification of Chronic Inflammation by Inhaled Carbon Monoxide in Patients With Stable Chronic Obstructive Pulmonary Disease (COPD)

PHASE2CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

January 31, 2005

Study Completion Date

March 31, 2006

Conditions
Pulmonary Disease, Chronic Obstructive
Interventions
DRUG

carbon monoxide

Trial Locations (1)

9700RB

University Medical Center Groningen, Department of Pulmonary Diseases, Groningen

All Listed Sponsors
collaborator

Stichting Astma Bestrijding, The Netherlands

OTHER

lead

Groningen Research Institute for Asthma and COPD

OTHER

NCT00122694 - Modification of Chronic Inflammation by Inhaled Carbon Monoxide in Patients With Stable Chronic Obstructive Pulmonary Disease (COPD) | Biotech Hunter | Biotech Hunter